Search Results
May 28, 2026, 15:21 ET What If You're Dreaming More Than You Realize?
activist, and author Ian Manuel, psychologist and bestselling author Sonja Lyubomirsky, and PhD, pediatrician and bestselling author Cara Natterson, MD.
More news about: Unlikely Collaborators
May 28, 2026, 14:07 ET John Joyoprayitno, Sarah Mayes, PhD, and Dan Peterson, MD Named Finalists for Entrepreneur Of The Year® 2026 Gulf South Award
May 28, 2026 /PRNewswire/ -- Alafair Biosciences today announced that co-founders John Joyoprayitno, Sarah Mayes, PhD, and Dan Peterson, MD are named finalists for the Entrepreneur Of The Year® 2026 Gulf South Award by Ernst & Young LLP (EY US).
More news about: Alafair Biosciences, Inc.
May 28, 2026, 13:47 ET Dr. Valinda Nwadike Announces Medical Student Scholarship Initiative
Advancing Maternal Health Equity, Rural Telehealth Innovation, and Future Physician LeadershipLEONARDTOWN, Md., May 28, 2026 /PRNewswire/ -- The
More news about: Dr. Valinda Nwadike Scholarship
May 28, 2026, 13:47 ET Dr. Andrew Hummel Scholarship for Medical Students Opens 2027 Applications Under Dr. Andrew Hummel to Support Future Physicians
patient care.Dr. Andrew Hummel, MD, is a Board-Certified Anesthesiologist and Medical Director with extensive experience in regional anesthesia, pain management, and medical optimization. His academic background includes the University of Missouri–Kansas City BA/MD program and residency training at
More news about: Dr. Andrew Hummel Scholarship
May 28, 2026, 13:45 ET /C O R R E C T I O N -- PartsSource/
central to care delivery, yet most health systems still manage service, uptime, and workforce capability in fragmented ways," said Philip Settimi, MSE, MD, President and CEO of PartsSource. "This study validates what leading clinical engineering professionals already know – when organizations apply evidence-based
More news about: PartsSource
May 28, 2026, 13:44 ET NORTHSTAR ANNOUNCES DATE FOR FIRST QUARTER 2026 FINANCIAL RESULTS AND VIRTUAL INVESTOR WEBCAST
"Company") is pleased to announce that it intends to file its unaudited quarterly financial statements and management's discussion and analysis ("MD&A") on SEDAR for the three months ended March 31, 2026 on Monday, June 1, 2026 after market close.
More news about: Northstar Clean Technologies Inc.
May 28, 2026, 13:34 ET DIIV Added to Music Performance Lineup at SilverVox Film + Music Festival
its hypnotic, layered sound to SilverVox – with a bonus screening of its film Boiled AliveFREDERICK, Md., May 28, 2026 /PRNewswire/ -- The inaugural SilverVox Film + Music Festival today announced that DIIV – the Brooklyn
More news about: SilverVox
May 28, 2026, 13:15 ET Braeburn Presents New Data at 2026 ASCP Annual Meeting Demonstrating Opioid Withdrawal Suppression at Low Buprenorphine Plasma Concentrations
picture of how buprenorphine works, particularly as the opioid crisis has evolved with the rise of high-potency synthetic opioids," said Joshua M. Cohen, MD, MPH, FAHS, Chief Medical Officer at Braeburn. "Data like these contribute to a more robust evidence base that may help inform individualized treatment
More news about: Braeburn
May 28, 2026, 12:46 ET Menarini Group Presents New Data from the Phase 1b/2 ELEVATE Study of Elacestrant in Combination with Capivasertib in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
ER+/HER2- PI3K-pathway altered metastatic breast cancer, particularly when co-existing ESR1 and PIK3CA mutations are present." said Sara Tolaney, MD, MPH, Chief of the Division of Breast Oncology, Dana-Farber Cancer Institute. "These encouraging preliminary data suggest the potential for extended
More news about: Menarini Industrie Farmaceutiche Riunite
May 28, 2026, 11:32 ET NeuLogiq® Platform Helps Confirm No Evidence of Psychotomimetic, Hallucinatory, or Dissociative Effects in a Phase 1b Study of a Novel Neuroplastogen Developed for Major Depressive Disorder
(DLX-001) in Major Depressive Disorder," was presented by Retsina Meyer, PhD, Head of Corporate Strategy at Delix Therapeutics, and Eliseo Salinas, MD, MSc, Head of Research & Development.Delix deployed the NeuLogiq Platform in a Phase 1b study of 18 adults with major depressive disorder,
More news about: Cumulus Neuroscience
May 28, 2026, 10:41 ET University of Chicago Urologist Performs First Commercial Vanquish® Water Vapor Ablation Procedures in the State
to IllinoisCHICAGO, May 28, 2026 /PRNewswire/ -- Abhinav Sidana, MD, a urologic oncologist at the University of Chicago Medicine (UChicago Medicine), has performed the first commercial Vanquish® Water Vapor Ablation procedure
More news about: Francis Medical, Inc.
May 28, 2026, 10:35 ET Florida Cancer Specialists & Research Institute Study Finds Comparable Quality and Safety Outcomes in CAR T-Cell Therapy Across Accredited and Non-Accredited Centers, Highlighting Care Location as Key Driver of Patient Access and Experience
Lucio N. Gordan, MD, FCS president and managing physician, a co-author of the abstract, said, "This study indicates that patients treated in non-FACT-accredited centers
More news about: Florida Cancer Specialists & Research Institute
May 28, 2026, 10:35 ET Prevent Blindness Declares June as Cataract Month, Providing Educational Resources on the Leading Cause of Vision Loss in the United States
Understanding Cataract" featuring Albert Cheung, MD, Cataract, Cornea, Anterior Segment Specialist with Virginia Eye Consultants and Assistant Professor at Eastern Virginia Medical School, Department of
More news about: Prevent Blindness
May 28, 2026, 10:30 ET Zuri Dental Announces New State-of-the-Art Dental Office Location in Rockville, MD
ROCKVILLE, Md., May 28, 2026 /PRNewswire/ -- Zuri
More news about: Zuri Dental
May 28, 2026, 10:00 ET Circulate Health Study Finds Plasma Exchange Removes Microplastics from the Human Bloodstream
learn more about the biological drivers of aging, it's becoming clear that cumulative environmental exposures play a meaningful role," said Eric Verdin, MD, co-founder of Circulate Health. "Microplastics are one such exposure, and studying them through well-controlled clinical approaches allows us to better
More news about: Circulate Health
May 28, 2026, 09:18 ET DOMA PERPETUAL CAPITAL MANAGEMENT QUESTIONS WHY SHAREHOLDERS SHOULD VOTE TO CONTINUE WITH A BOARD THAT HAS OVERSEEN A DECADE OF VALUE DESTRUCTION
shareholders that support our mission to install new voices and perspectives in the Pacira Boardroom to vote FOR all three DOMA nominees, Christopher Dennis, MD, MBA, FAPA, Oliver Benton "Ben" Curtis III, and Eric de Armas, using the WHITE proxy card in advance of the June 9, 2026, annual meeting.Contact:DOMA
More news about: DOMA Perpetual
May 28, 2026, 09:15 ET CULINARY INSTITUTE OF AMERICA INTRODUCES FOOD IS LIFE, FOOD IS HEALTH SUMMIT
Eisenberg, MD, director of culinary nutrition and adjunct associate professor of nutrition at Harvard T. H. Chan School of Public Health; registered dietitian nutritionists Maya Feller, Breana Killeen, and Sapna Punjabi; CIA grad and two-time Top Chef finalist Gregory Gourdet; Lloyd Minor, MD, dean, Stanford
More news about: The Culinary Institute of America
May 28, 2026, 09:15 ET Illumina introduces the first distributed whole-genome sequencing solution for highly sensitive MRD research
participating in early access and evidence generation for a tumor-informed, non-bespoke whole-genome sequencing approach to MRD," said Gang Zheng, MD, PhD and professor of Laboratory Medicine and Pathology at Mayo Clinic. "We have seen early pilot results across several solid tumor clinical samples that demonstrated
More news about: Illumina, Inc.
May 28, 2026, 09:06 ET Theranica Advances Nerivio® as a Transformative Therapy for Personalized Migraine Care
underlying algorithm will be featured at the upcoming American Headache Society Scientific Meeting in Orlando, Florida, June 4-6, 2026, when Peter Goadsby, MD, PhD, DSc, FRS, FAHS, King Abdullah University of Science and Technology, Saudi Arabia, is scheduled to discuss the clinical relevance of this new capability
More news about: Theranica
May 28, 2026, 09:00 ET ASCO Using Ryght AI's Advanced Platform to Accelerate Site Selection for Breast Cancer Clinical Trial
assessments and site activation."Patients with metastatic breast cancer cannot afford to wait for access to clinical trials," said Julie R. Gralow, MD, FACP, FASCO, Chief Medical Officer and Executive Vice President of ASCO. "This collaboration aims to activate the most suitable sites faster and reach
More news about: Ryght
May 28, 2026, 09:00 ET Fairfax City Economic Development and The Navy Co-Host Sensors & Autonomy Reverse Pitch Day
WEST BETHESDA, Md., May 28, 2026 /PRNewswire/ --
More news about: Fairfax City Economic Development
May 28, 2026, 09:00 ET Claroty Introduces Claire, Industry's First CPS-Native AI Security Agent
learn more about Claroty's CPS-native security agent, Claire, visit booth 315 at the Gartner Security & Risk Summit, June 1-3 in National Harbor, MD. Find more information on the Claroty
More news about: Claroty
May 28, 2026, 09:00 ET Zydus Therapeutics New Drug Application (NDA) for Saroglitazar to Treat Primary Biliary Cholangitis (PBC) Granted Priority Review by the US FDA
endpoint, demonstrating a clinically meaningful biochemical response, along with a favorable safety and tolerability profile," said Raj Vuppalanchi, MD, Professor of Medicine at Indiana University School of Medicine and Global Principal Investigator for the EPICS-III study.In the trial (N = 148),
More news about: Zydus Therapeutics, Inc.
May 28, 2026, 08:54 ET Florida Cancer Specialists & Research Institute Advances the Future of Cancer Care
Judy Wang, MD, FCS associate director of drug development, Sarasota Drug Development UnitA first-in-human study of ATX-295, an oral inhibitor of KIF18A, in patients with advanced or metastatic solid tumors, including ovarian cancer.Judy Wang, MD and
More news about: Florida Cancer Specialists & Research Institute
May 28, 2026, 08:44 ET Harvard-Trained Spine Surgeon Dr. Babajide Ogunseinde Expands PML Mastery Ecosystem With Release of New PML Book Trilogy
Medical School. He is also working towards his MBA in organizational management in the fall of 2026.MEDIA CONTACTBabajide Ogunseinde, MD, MBA (2026)Founder, PML Global InitiativeEmail: [email protected]
More news about: PML Mastery